3D printing improves accuracy, personalization of prosthetic implants

Researchers have developed accurate, personalized prosthetic implants for the middle ear using CT scans and 3D printing, according to a study presented at the annual Radiological Society of North America (RSNA) meeting.

Currently, treating patients with conductive hearing loss involves surgical reconstruction using prostheses made from steel and ceramic cups. However, this treatment method has a high rate of failure due to the lack of personalization in the implants. In this study, researchers test the effectiveness of implants developed using CT scans and 3D printing.

"The ossicles are very small structures, and one reason the surgery has a high failure rate is thought to be due to incorrect sizing of the prostheses," said study author Jeffrey D. Hirsch, MD, assistant professor of radiology at the University of Maryland School of Medicine (UMSOM) in Baltimore. "If you could custom-design a prosthesis with a more exact fit, then the procedure should have a higher rate of success."

Researchers started by removing the middle linking ossicular chain bone from three cadavers and imaged the structure using CT scans. The scans where then used to recreate a 3D printed prosthesis fitting each ear. Following the experimentation, four surgeons were tasked with inserting the prosthesis into the middle ear of the cadaver to test the implant's accuracy in fitting to the original bone's place. Results showed all four surgeons were able to correctly place the prothesis in its intended bone.

"This study highlights the core strength of 3D printing—the ability to very accurately reproduce anatomic relationships in space to a sub-millimeter level. With these models, it's almost a snap fit,” concluded Dr. Hirsch. “The results suggest that commercially available CT scanners can detect significant anatomic differences in normal human middle ear ossicles, and that these differences can be accurately represented with current 3D printing technology. More significantly, surgeons can detect these differences, which should not only increase the likelihood of a proper fit, but also decrease surgical time.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.